Longato, Enrico
Di Camillo, Barbara
Sparacino, Giovanni
Tramontan, Lara
Avogaro, Angelo
Fadini, Gian Paolo http://orcid.org/0000-0002-6510-2097
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (Departments of Excellence" (Law 232/2016))
Article History
Received: 2 April 2020
Accepted: 5 June 2020
First Online: 10 June 2020
Ethics approval and consent to participate
: The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. All the data used in this study were previously anonymized as per the Italian law concerning their usage for research and governance purposes. Study conduct was approved by the data owner board (Arsenàl.IT) and a formal ethics approval was deemed not necessary. Based on national regulations for retrospective studies on anonymized administrative claims, patients’ informed consent was not collected.
: Not applicable.
: AA received research grants, lecture or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, and Takeda. GPF received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp-Dome, Mundipharma, Novartis, Novo Nordisk, Sanofi, Servier. EL, BDC, GS, LT have nothing to disclose.